第690号委员会意见摘要:基因组医学时代的携带者筛查
该委员会意见指出,针对特定种族、泛种族和扩展性携带者筛查均可作为孕前和产前携带者筛查的可接受策略,每位妇产科医生或其他医疗保健提供者或诊所应建立一致的标准方法,最好在孕前提供并讨论。筛查为可选项目,患者可拒绝任何或全部携带者筛查,应就残留风险进行咨询,扩展性携带者筛查不替代既往基于风险的筛查建议。
要点
- 针对特定种族、泛种族和扩展性携带者筛查均为孕前和产前携带者筛查可接受的策略。
- 每位妇产科医生或其他医疗保健提供者或诊所应建立一致的标准方法,最好在孕前提供并讨论。
- 筛查为可选项目,患者可拒绝任何或全部携带者筛查,应就残留风险进行咨询。
核心结论
- 针对特定种族、泛种族和扩展性携带者筛查均为孕前和产前携带者筛查可接受的策略。
- 每位妇产科医生或其他医疗保健提供者或诊所应建立一致的标准方法,最好在孕前提供并讨论。
- 筛查为可选项目,患者可拒绝任何或全部携带者筛查;应就残留风险进行咨询。
- 扩展性携带者筛查不替代既往基于风险的筛查建议。
- 对有遗传病家族史或担忧遗传诊断的患者,应考虑转诊至具有遗传学专长的妇产科医生或其他医疗保健提供者进行风险评估、评估和考虑诊断性检测。
研究设计与样本
- 该文件为美国妇产科医师学会(American College of Obstetricians and Gynecologists)发布的第690号委员会意见摘要。
关键数值与推荐
- 针对特定种族、泛种族和扩展性携带者筛查均为孕前和产前携带者筛查可接受的策略。
- 每位妇产科医生或其他医疗保健提供者或诊所应建立一致的标准方法,最好在孕前提供并讨论。
- 筛查为可选项目,患者可拒绝任何或全部携带者筛查;应就残留风险进行咨询。
- 若患者要求采用不同于其妇产科医生或其他医疗保健提供者所用策略的筛查策略,应在就局限性、益处和替代方案进行咨询后向其提供所要求的检测。
- 扩展性携带者筛查不替代既往基于风险的筛查建议。
临床怎么用
- 妇产科医生或其他医疗保健提供者或诊所应建立一致的标准携带者筛查方法,最好在孕前提供并讨论。
- 应就残留风险进行咨询,并告知患者筛查为可选项目,患者可拒绝任何或全部携带者筛查。
- 若患者要求采用不同于医生所用策略的筛查策略,应在就局限性、益处和替代方案进行咨询后向其提供所要求的检测。
- 对有遗传病家族史或担忧遗传诊断的患者,应考虑转诊至具有遗传学专长的妇产科医生或其他医疗保健提供者。
局限性
- 携带者筛查不会识别所有处于所筛查疾病风险中的个体。
- 患者应就任何检测结果的残留风险进行咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Carrier screening, whether targeted or expanded, allows individuals to consider their range of reproductive options. Ultimately, the goal of genetic screening is to provide individuals with meaningful information that they can use to guide pregnancy planning based on their personal values. Ethnic-specific, panethnic, and expanded carrier screening are acceptable strategies for prepregnancy and prenatal carrier screening. Because all of these are acceptable strategies, each obstetrician-gynecologist or other health care provider or practice should establish a standard approach that is consistently offered to and discussed with each patient, ideally before pregnancy. Carrier screening will not identify all individuals who are at risk of the screened conditions. Patients should be counseled regarding the residual risk with any test result. Screening for any condition is optional and, after counseling, a patient may decline any or all carrier screening. If a patient requests a screening strategy other than the one used by the obstetrician-gynecologist or other health care provider, the requested test should be made available to her after counseling on its limitations, benefits, and alternatives. Expanded carrier screening does not replace previous risk-based screening recommendations. The determination of the appropriate screening approach for any individual patient should be based on the patient's family history and personal values after counseling. Referral to an obstetrician-gynecologist or other health care provider with genetics expertise should be considered for risk assessment, evaluation, and consideration of diagnostic testing as indicated for any patient with a family history of a genetic condition or concern for a genetic diagnosis.
引用
- Committee Opinion No. 690 Summary: Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017. PMID: 28225420. doi:10.1097/AOG.0000000000001947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。